PS Ratio: 74.25

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 74.25 is 23% below its estimated 1-year average of 96.92, near the low end of its estimated 1-year range (74.25–124.62).

As of 2026-10-06T16:34:15.413Z.

RAPP PS Ratio Metrics

P/S vs. estimated history

At 74.25, P/S is below its estimated 1-year median — higher than 0% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Rapport Therapeutics, Inc. Common Stock (RAPP)?

The P/S ratio for RAPP stock is 74.25.

Is Rapport Therapeutics, Inc. Common Stock's P/S ratio high or low?

The P/S ratio of 74.25 is 23% below its estimated 1-year average of 96.92, near the low end of its estimated 1-year range (74.25–124.62).

Related Metrics